Cargando…

Current Diagnosis and Management of Tangier Disease

Tangier disease is a genetic disorder characterized by an absence or extremely low level of high-density lipoprotein (HDL)-cholesterol (HDL-C). It is caused by a dysfunctional mutation of the ATP-binding cassette transporter A1 ( ABCA1 ) gene, the mandatory gene for generation of HDL particles from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koseki, Masahiro, Yamashita, Shizuya, Ogura, Masatsune, Ishigaki, Yasushi, Ono, Koh, Tsukamoto, Kazuhisa, Hori, Mika, Matsuki, Kota, Yokoyama, Shinji, Harada-Shiba, Mariko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326168/ https://www.ncbi.nlm.nih.gov/pubmed/33994407 http://dx.doi.org/10.5551/jat.RV17053

Ejemplares similares

Diagnosis and Management of Sitosterolemia 2021
por: Tada, Hayato, et al.
Publicado: (2021)

Current Diagnosis and Management of Abetalipoproteinemia
por: Takahashi, Manabu, et al.
Publicado: (2021)

Current Status of Familial LCAT Deficiency in Japan
por: Kuroda, Masayuki, et al.
Publicado: (2021)

Current Diagnosis and Management of Primary Chylomicronemia
por: Okazaki, Hiroaki, et al.
Publicado: (2021)

Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
por: Koyama, Shingo, et al.
Publicado: (2021)

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
por: Michikura, Masahito, et al.
Publicado: (2022)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene
por: Tada, Hayato, et al.
Publicado: (2022)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
por: Hori, Mika, et al.
Publicado: (2020)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Guidance for Pediatric Familial Hypercholesterolemia 2017
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Accelerated Atherogenicity in Tangier Disease: A Case Accompanied by Extensive Atherosclerotic Lesions, Leriche Syndrome and Bleeding Tendency, and Review of the Literature
por: Muratsu, Jun, et al.
Publicado: (2018)

Association between Familial Hypercholesterolemia and Serum Levels of Cholesterol Synthesis and Absorption Markers: The CACHE Study FH Analysis
por: Matsuki, Kota, et al.
Publicado: (2023)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
por: Funabashi, Sayaka, et al.
Publicado: (2022)

A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency
por: Nishikawa, Ryo, et al.
Publicado: (2022)

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Ogura, Masatsune, et al.
Publicado: (2022)

Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

The English hospital, Tangier, 1883-1908.
por: Sims, A C
Publicado: (1972)

Gradual dose Titration of Lomitapide may Prevent Therapeutic Delays in Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

Clinical utility gene card for: Tangier disease
por: Hooper, Amanda J, et al.
Publicado: (2017)

Tangier Disease: An Unusual Cause of Chronic Diarrhea
por: Ritaccio, Gabrielle, et al.
Publicado: (2021)

Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
por: Harada-Shiba, Mariko, et al.
Publicado: (2023)

The iPSC Awakens ANGPTL3 in Tangier Disease
por: Lee, Man K.S., et al.
Publicado: (2017)

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia
por: Yamashita, Shizuya, et al.
Publicado: (2020)

Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society
por: Funabashi, Sayaka, et al.
Publicado: (2021)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

Climate Change and the Evolution and Fate of the Tangier Islands of Chesapeake Bay, USA
por: Schulte, David M., et al.
Publicado: (2015)

VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body
por: Yamamoto, Hideaki, et al.
Publicado: (2017)

Effects of miglustat treatment in a patient affected by an atypical form of Tangier disease
por: Sechi, Annalisa, et al.
Publicado: (2014)

Platelet activating factor levels and metabolism in tangier disease: a case study
por: Kolovou, Vana, et al.
Publicado: (2012)

Association of a Novel Homozygous Variant in ABCA1 Gene with Tangier Disease
por: Barbosa-Gouveia, Sofía, et al.
Publicado: (2023)

Interpreting New Thoughts on HDL Through the Lens of Chesapeake Bay’s Tangier Disease
por: Tabacco, John, et al.
Publicado: (2023)

Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis
por: Shoji, Tetsuo, et al.
Publicado: (2022)

Relationship between Diabetes Mellitus and Serum Lathosterol and Campesterol Levels: The CACHE Study DM Analysis
por: Matsumura, Takeshi, et al.
Publicado: (2023)

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report
por: Iitake, Chie, et al.
Publicado: (2020)

Serum Values of Cholesterol Absorption and Synthesis Biomarkers in Japanese Healthy Subjects: The CACHE Study HEALTHY Analysis
por: Ishibashi, Yutaka, et al.
Publicado: (2023)

Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
por: Doi, Takahito, et al.
Publicado: (2021)

Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy
por: Nagappa, Madhu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3mfna070e6j4drjcamj4uu719u